Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
181-195 of 427
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
On the Frontlines of Colorectal CancerEvolving Strategies in CRC Care: Screening, Treatment, and Equity
Ryan Quigley
Thomas Cataldo, MD
Sowmya Sharma, MD
Prioritizing Quality of Life in CRC: Key Surgical Considerations
On the Frontlines of Colorectal CancerPrioritizing Quality of Life in CRC: Key Surgical Considerations
Ryan Quigley
Thomas Cataldo, MD
Sowmya Sharma, MD
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Jennifer Caudle, DO, FACOFP
Mansi R. Shah, MD
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®Predicting Breast Cancer Metastasis with Proteomics
- advertisement
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®Advancing HER2-Targeted Therapy in GI Cancers
John H. Strickler, MD
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast CancerHER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP
Heather Parsons
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Project Oncology®Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Daniela Molena, MD
- advertisement
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®How AI Is Transforming Biomarker Development in GI Oncology
William Hall, MD
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast CancerHow ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP
Nick McAndrew, MD, MSCE
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerExploring T-DXd in HER2-Positive Breast Cancer Treatment
Charles Turck, PharmD, BCPS, BCCCP
Jules Cohen, MD
